Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives

被引:16
|
作者
Deb, Pran Kishore [1 ]
Chandrasekaran, Balakumar [1 ]
Mailavaram, Raghuprasad [2 ]
Tekade, Rakesh Kumar [3 ]
Jaber, Abdul Muttaleb Yousef [1 ]
机构
[1] Philadelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
[2] Sri Vishnu Coll Pharm, Pharmaceut Chem Div, Bhimavaram 534202, Andhra Pradesh, India
[3] NIPER, Opposite Air Force Stn Palaj, Gandhinagar 382355, Gujarat, India
关键词
PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; BINDING MODES; XANTHINE DERIVATIVES; DYNAMICS SIMULATIONS; MEDICINAL CHEMISTRY; AFFINITY; POTENT; QSAR;
D O I
10.1016/j.drudis.2019.05.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine receptors (ARs) are classified as A(1), A(2A),A(2B), and A(3) subtypes belonging to the superfamily of G-protein-coupled receptors (GPCRs). Several molecular modeling approaches have been developed for A(2B)AR and its antagonists, from the construction of a homology model, molecular docking, molecular dynamics (MD) simulations, and 3D quantitative structure-activity relationship (QSAR) modeling to pharmacophore modeling, each of which has different objectives and outcomes. In this review, we provide a systematic outline of advances in molecular modeling approaches towards A(2B)AR for deducing its structure and interactions with various types of antagonist. The information, methods and perspectives presented here provides impetus for medicinal chemists to discover potential ligands that can bind selectively with higher affinity to A(2B)AR.
引用
收藏
页码:1854 / 1864
页数:11
相关论文
共 50 条
  • [31] Do adenosine receptor antagonists have an antidiabetic effect mediated by A2B receptors?
    Verspohl, EJ
    Rüsing, D
    Müller, CE
    DIABETOLOGIA, 2005, 48 : A169 - A169
  • [32] Characterization of novel dual A2A/A2B adenosine receptor antagonists for cancer immunotherapy
    Galezowski, Michal
    Wegrzyn, Paulina
    Bobowska, Aneta
    Commandeur, Claude
    Dziedzic, Katarzyna
    Nowogrodzki, Marcin
    Obara, Alicja
    Szeremeta-Spisak, Joanna
    Dzielak, Anna
    Lozinska, Iwona
    Dudek, Marcelina
    Janiga, Anita
    Reus, Jacek
    Wronowski, Marek
    Swirski, Mateusz
    Radzimierski, Adam
    Ziembik, Magdalena
    Mierzwicka, Joanna
    Wojcik-Jaszczynska, Katarzyna
    Gocek, Elzbieta
    Grycuk, Karolina
    Golas, Aniela
    Pierzchala, Olga
    Zachmann, Julian
    Nowak, Mateusz
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Endothelin receptor antagonists: Current status and perspectives
    Clozel, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 : S65 - S68
  • [34] A2B adenosine receptor signaling and regulation
    Gao, Zhan-Guo
    Haddad, Mansour
    Jacobson, Kenneth A.
    PURINERGIC SIGNALLING, 2024,
  • [35] Ligands for A2B adenosine receptor subtype
    Baraldi, Pier Giovanni
    Romagnoli, Romeo
    Preti, Delia
    Fruttarolo, Francesca
    Carrion, Maria Dora
    Tabrizi, Mojgan Aghazadeh
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (28) : 3467 - 3482
  • [36] The resurgence of A2B adenosine receptor signaling
    Aherne, Carol M.
    Kewley, Emily M.
    Eltzschig, Holger K.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2011, 1808 (05): : 1329 - 1339
  • [37] Selective and potent antagonists for adenosine A2B receptors.
    Kim, YC
    Ji, XD
    Linden, J
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U960 - U960
  • [38] 3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists
    Wei, Jing
    Wang, Songqing
    Gao, Shaofen
    Dai, Xuedong
    Gao, Qingzhi
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) : 613 - 625
  • [39] Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A2B adenosine receptor antagonists
    Eastwood, Paul
    Gonzalez, Jacob
    Paredes, Sergio
    Nueda, Arsenio
    Domenech, Teresa
    Alberti, Joan
    Vidal, Bernat
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1697 - 1700
  • [40] A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives
    Basu, Sujay
    Barawkar, Dinesh A.
    Ramdas, Vidya
    Waman, Yogesh
    Patel, Meena
    Panmand, Anil
    Kumar, Santosh
    Thorat, Sachin
    Bonagiri, Rajesh
    Jadhav, Dilip
    Mukhopadhyay, Partha
    Prasad, Vandna
    Reddy, B. Srinivasa
    Goswami, Arnab
    Chaturvedi, Sandhya
    Menon, Suraj
    Quraishi, Azfar
    Ghosh, Indraneel
    Dusange, Sushant
    Paliwal, Shalini
    Kulkarni, Abhay
    Karande, Vikas
    Thakre, Rhishikesh
    Bedse, Gaurav
    Rouduri, Sreekanth
    Gundu, Jayasagar
    Palle, Venkata P.
    Chugh, Anita
    Mookhtiar, Kasim A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 986 - 996